Yuling Xu

Yuling Xu

Auto-generated profile, based on publicly available information

Yuling Xu

National Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry Central China Normal University Wuhan 430079 China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
YXYuling Xu
Yuling Xu
YPYida Pang
Yida Pang
LLLishi Luo
Lishi Luo
ASAmit Sharma
Amit Sharma
JYJingfang Yang
Jingfang Yang
YSYan Sun
Yan Sun

1 October 2014 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
ZJZhenyuan Ji
Zhenyuan Ji
XSXiaoping Shen
Xiaoping Shen
YXYuling Xu
Yuling Xu
GZGuoxing Zhu
Guoxing Zhu
KCKangmin Chen
Kangmin Chen

18 October 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
WXWeiqing Xu
Weiqing Xu
YWYu Wu
Yu Wu
YXYuling Xu
Yuling Xu
Xiaoli CaiXiaoli Cai
Xiaoli Cai
WGWenling Gu
Wenling Gu
Chengzhou ZhuChengzhou Zhu
Chengzhou Zhu

23 February 2024 in Angewandte Chemie
Verified
Journal Article
Closed access
YXYuling Xu
Yuling Xu
YPYida Pang
Yida Pang
LLLishi Luo
Lishi Luo
ASAmit Sharma
Amit Sharma
JYJingfang Yang
Jingfang Yang
YSYan Sun
Yan Sun

24 August 2026 in Advanced Science
Verified
Journal Article
Open access
YZYan Zhao
Yan Zhao
YLYufei Lan
Yufei Lan
MLMin‐Goo Lee
Min‐Goo Lee
JHJinjun He
Jinjun He
YPYueran Pan
Yueran Pan
CZChao Zhang
Chao Zhang
Precision control over nucleic acid delivery remains a critical challenge in cancer therapy, particularly for siRNA‐based gene silencing, where off‐target effects limit clinical translation. Herein, we report a programmably engineered DNA nanocircuit with cascaded dual‐AND logic gates, which enables the development of a spatiotemporally controlled siRNA delivery strategy for precision cancer therapy. The DNA nanocircuit is engineered to respond to three tumor‐specific signals in a sequential manner: extracellular acidic pH, membrane‐overexpressed nucleolin (NCL), and intracellular glutathione (GSH). The first AND gate is activated by the co‐occurrence of acidic pH and NCL, triggering a conformational rearrangement that generates a molecular output. This integrated output, combined with intracellular GSH, serves as the dual input to co‐activate the second AND gate, initiating siRNA release via a cascade reaction inherent to the DNA circuit. As a proof‐of‐concept, when harnessing this DNA circuit in a temozolomide (TMZ)‐resistant glioblastoma (GBM) mouse model, we demonstrate that this design ensures highly selective release of siPARP1 in GBM cells, achieving efficient PARP1 silencing, reversed TMZ resistance, and minimized off‐target toxicity. Collectively, the cascaded dual‐AND logic, enabled by precise DNA sequence programming, represents a generalizable strategy for multi‐signal‐responsive delivery systems, highlighting the potential of DNA circuits in precision cancer therapy.